Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regencell Bioscience Holdings Limited - Ordinary Shares (NQ:RGC)

28.69 -0.51 (-1.75%)
Streaming Delayed Price Updated: 1:26 PM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 71,855
Open 28.52
Bid (Size) 28.57 (300)
Ask (Size) 28.81 (200)
Prev. Close 29.20
Today's Range 28.12 - 30.00
52wk Range 9.390 - 950.00
Shares Outstanding 13,012,866
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC
From The Rosen Law Firm PA
Via GlobeNewswire

Performance

YTD
+39.7%
+39.7%
1 Month
+23.0%
+23.0%
3 Month
-1.7%
-1.7%
6 Month
+73.8%
+73.8%
1 Year
-16.5%
-16.5%

More News

Read More
News headline image
REGENCELL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
RGC Stock Gains 20% Pre-Market — Retail Says Shorts Are In ‘Huge Trouble’ ↗
Via Stocktwits
News headline image
Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action
From Robbins LLP
Via Business Wire
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
News headline image
Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now ↗
Via The Motley Fool
News headline image
Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag ↗
Via The Motley Fool
News headline image
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need ↗
Via The Motley Fool
Top movers in Thursday's session ↗
Via Chartmill
Thursday's session: top gainers and losers ↗
Via Chartmill
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
These stocks are gapping in today's session ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Regencell Bioscience (RGC) Stumbles into 2026: 8% Year-End Slide Sparks Technical Caution
Via MarketMinute
News headline image
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is Regencell Bioscience Holdings Limited - Ordinary Shares publicly traded?
Yes, Regencell Bioscience Holdings Limited - Ordinary Shares is publicly traded.
What exchange does Regencell Bioscience Holdings Limited - Ordinary Shares trade on?
Regencell Bioscience Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares?
The ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares is RGC on the Nasdaq Stock Market
What is the current price of Regencell Bioscience Holdings Limited - Ordinary Shares?
The current price of Regencell Bioscience Holdings Limited - Ordinary Shares is 28.69
When was Regencell Bioscience Holdings Limited - Ordinary Shares last traded?
The last trade of Regencell Bioscience Holdings Limited - Ordinary Shares was at 04/28/26 01:26 PM ET
What is the market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares?
The market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares is 373.34M
How many shares of Regencell Bioscience Holdings Limited - Ordinary Shares are outstanding?
Regencell Bioscience Holdings Limited - Ordinary Shares has 373M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.